(Last updated : 2025-10-02 14:16:57)
  ISHIYAMA Yuudai
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Research Associate
■ Published papers
1. Original article  An RMST-based analysis of systemic therapy in muscle-invasive bladder cancer. 2025/10
2. Original article  Outcomes of enfortumab vedotin treatment in patients ineligible for the EV‐301 trial. 2025/09
3. Other  A restricted mean survival time based analysis of systemic therapy sequencing in muscle-invasive bladder cancer. 2025/05 Link
4. Other  Re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of patients with brain metastases from renal cell carcinoma receiving first-line therapies: Results from the international metastatic renal cell carcinoma database consortium. 2024/12
5. Original article  Impact of tumor dissecting technique on trifecta achievement in patients requiring extended warm ischemia during robot-assisted partial nephrectomy. 2024/10/18
Display all(26)
■ Academic conference presentation
1. A restricted mean survival time based analysis of systemic therapy sequencing in muscle-invasive bladder cancer. (Poster notice,General) 2025/04/29
2. Clinicopathological evaluation of living-related kidney transplantation from older adult donors: A focus on zero-time
biopsy findings. (Poster notice,General) 2024/06/04
3. Greater impact of tumor dissecting technique on trifecta achievement in patients requiring extended warm ischemia during robotic-assisted partial nephrectomy. (Poster notice,General) 2024/05/06
4. Patient and tumor profile differences for early and late recurrences following radical resection for high-risk renal cell carcinoma. (Poster notice,General) 2024/05/05
5. Prognostic impact of lung immune prognostic index in recurrence after radical surgery for high-risk renal cell carcinoma. (Poster notice,General) 2024/05/05
Display all(25)